Board et al., 1993 - Google Patents
Factor XIII: inherited and acquired deficiencyBoard et al., 1993
- Document ID
- 5516233865705326272
- Author
- Board P
- Lososky M
- Miloszewski K
- Publication year
- Publication venue
- Blood reviews
External Links
Snippet
Factor XIII (XIII), an enzyme found in plasma (present as a pro-enzyme), platelets and monocytes, is essential for normal haemostasis. It may also have a role to play in the processes of wound healing and tissue repair. Inherited XIII deficiency results in a life-long …
- 108010071289 Factor XIII 0 title abstract description 103
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Board et al. | Factor XIII: inherited and acquired deficiency | |
Sakata et al. | Significance of cross-linking of α 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis | |
McDonagh Jr et al. | The influence of fibrin crosslinking on the kinetics of urokinase‐induced clot lysis | |
Mutch et al. | TAFIa, PAI‐1 and α2‐antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots | |
Mosesson | Fibrin polymerization and its role in regulating hemostasis | |
Aoki et al. | Fibrinolytic states in a patient with congenital deficiency of α2-plasmin inhibitor | |
Mutch et al. | Model thrombi formed under flow reveal the role of factor XIII‐mediated cross‐linking in resistance to fibrinolysis | |
Aeschlimann et al. | Transglutaminases: protein cross-linking enzymes in tissues and body fluids | |
Bouma et al. | Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) | |
Gemmati et al. | Coagulation factor XIIIA (F13A1): novel perspectives in treatment and pharmacogenetics | |
Rijken et al. | Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII | |
Tamao et al. | Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo | |
Teng et al. | Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin | |
US20060216280A1 (en) | Fibrinogen-based tissue adhesive containing an elastase inhibitor | |
Bouma et al. | New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R) | |
Kluft | t-PA in fibrin dissolution and hemostasis | |
Mimuro et al. | Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. | |
Mitchell et al. | Novel aspects of platelet factor XIII function | |
Guerrero et al. | Lonomia achelous caterpillar venom (LACV) selectively inactivates blood clotting factor XIII | |
Bretschneider et al. | Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells | |
Nilsson | Coagulation and fibrinolysis | |
Howes et al. | Effects of three novel metalloproteinases from the venom of the West African saw-scaled viper, Echis ocellatus on blood coagulation and platelets | |
Geenen et al. | Coagulation on endothelial cells: the underexposed part of Virchow’s Triad | |
JP5236952B2 (en) | FXIII variant with improved properties | |
Walker et al. | Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity |